Cambridge Cognition Holdings PLC develops proprietary technologies for cognitive assessment, focusing on brain health. Its primary products include digital touchscreen assessments known as CANTAB® and voice-based assessments, enhanced through the acquisition of Winterlight Labs. The company serves four market segments: Clinical Studies, Academic Research, Healthcare, and Consumer Health & Wellness, with a significant portion of revenue derived from supporting clinical studies for pharmaceutical companies. Cambridge Cognition operates primarily in the healthcare sector, targeting customers in clinical, academic, and consumer markets globally.